DocGo Inc. (DCGO)
Healthcare
- Fundamental
- 1
- Sentiment
- 1
- Technical
- 1
Do Nothing: fundamentalScore 1 and qualitativeScore 1 are both below the required floor of 3 (going-concern/distressed issuer), liquidity fails the $5M floor (avgDollarVolume20 ≈ $0.49M) and the $1.5M recent floor (≈ $0.56M), and the post-earnings overnight gap of ~17.5% exceeds 5%; no tradable long.
Company overview
DocGo Inc. provides mobile healthcare solutions and medical transportation services in the United States and the United Kingdom. The company offers emergency and non-emergency medical transportation, as well as mobile health services directly to patients' locations. Founded in 2015, DocGo also supports events with on-site healthcare services.
Fundamental
very weakDocGo faces severe financial challenges, including going-concern issues and a breached liquidity covenant.
DocGo is a distressed situation: the FY2025 10-K and the Q2 2026 10-Q both carry an explicit substantial-doubt going-concern conclusion, the company ended 2025 in breach of its credit facility's minimum-liquidity covenant with no revolver access, and Nasdaq issued a minimum-bid-price delisting notice while the stock trades near $0.38. Revenue fell 47.7% in FY2025 on the wind-down of New York migrant-services contracts and kept falling in H1 2026; the FY2025 loss was amplified by roughly $89M of non-cash impairments, but H1 2026 operating cash burn of $13.9M shows the weakness is now corroborated on a cash basis. Mitigants - $25M cash, positive working capital, a stable Transportation segment, and a signed Hicuity Health merger with up to $50M of Perceptive senior secured financing - do not offset the existential risks today, and the merger adds about $102M of combined senior secured term debt before it closes. Verdict: too risky to invest; re-evaluate only once the going concern is resolved and the deal actually closes.
Sentiment
very weakSentiment is capped by going-concern warnings and delisting risks, with no bullish catalysts.
Severe red-flag cap applied — going-concern/substantial-doubt language reiterated in the late-filed Q2 2026 10-Q (2026-08-17) caps the qualitative read at the severe-flag ceiling. The in-window tape is flat-mixed (polarity_score ≈ +0.03): a regulator-confirmed Hicuity Health acquisition (bullish, 2026-08-16) offsets a loss-widening, revenue-declining Q2 print (bearish) while the Nasdaq minimum-bid compliance process remains unresolved through 2027-01-25; sentiment delta is indeterminate on a sparse baseline (2 unique on-topic items).
Technical
very weakThe stock is in a strong downtrend with negative momentum and no bullish confirmation.
Price is in a strong downtrend below all key moving averages with negative momentum after the Q2 print; oversold (RSI14 30.8, Williams %R -99.97) but ADX 29.2 confirms trend strength to the downside; broken structure with no bullish confirmation — chart quality scores 1 (bearish/broken structure).
You’re looking at 2026-08-25 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.

